Stason Pharmaceuticals is a global pharmaceutical company headquartered in Irvine, CA. With over 26 years of experience in the industry, Stason is committed to developing high-quality drugs and building strategic partnerships. Their core therapeutic categories include oncology, renal, and orphan indications.

Stason offers a range of services through their contract service divisions, MPhS and Western PharmSci. These services include contract packaging, analytical testing, and contract manufacturing for clinical trial materials, with an option for commercial production of high potency products. The company also has a strong presence in the US generic market, having entered in 1994.

They currently hold a portfolio of generic products, ensuring affordable and accessible medications for patients. Stason's cutting-edge manufacturing capabilities, including facilities from pilot plant to high containment, allow them to meet rigorous quality standards. With a global network of manufacturers in the US, Canada, Europe, and Asia, Stason excels in global sourcing and ensures a diverse supply chain.

To learn more about Stason Pharmaceuticals and their comprehensive range of services, visit their website